BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24708648)

  • 1. Association of two common polymorphisms of apolipoprotein A5 gene with metabolic syndrome indicators in a North Iranian population, a cross-sectional study.
    Halalkhor S; Jalali F; Tilaki KH; Shojaei S
    J Diabetes Metab Disord; 2014; 13():48. PubMed ID: 24708648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults.
    Komurcu-Bayrak E; Onat A; Poda M; Humphries SE; Palmen J; Guclu F; Can G; Erginel-Unaltuna N
    Clin Chem Lab Med; 2008; 46(6):778-84. PubMed ID: 18601598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
    Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
    Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study.
    Ariza MJ; Sánchez-Chaparro MA; Barón FJ; Hornos AM; Calvo-Bonacho E; Rioja J; Valdivielso P; Gelpi JA; González-Santos P
    BMC Med Genet; 2010 Apr; 11():66. PubMed ID: 20429872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOA5-1131T>C genotype effects on apolipoprotein A5 and triglyceride levels in response to dietary intervention and regular exercise (DIRE) in hypertriglyceridemic subjects.
    Jang Y; Chae JS; Kim OY; Park HJ; Kim JY; Paik JK; Lee SH; Lee JH
    Atherosclerosis; 2010 Aug; 211(2):512-9. PubMed ID: 20392444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein A5 polymorphisms in Turkish population: association with serum lipid profile and risk of ischemic stroke.
    Can Demirdöğen B; Şahin E; Türkanoğlu Özçelik A; Bek S; Demirkaya Ş; Adali O
    Mol Biol Rep; 2012 Dec; 39(12):10459-68. PubMed ID: 23065249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Relation between Metabolic Syndrome Risk Factors and Genetic Variations of Apolipoprotein V in Relation with Serum Triglyceride and HDL-C Level.
    Fallah MS; Sedaghatikhayat B; Guity K; Akbari F; Azizi F; Daneshpour MS
    Arch Iran Med; 2016 Jan; 19(1):46-50. PubMed ID: 26702748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haplotype analysis of the Apolipoprotein A5 gene in Moroccan patients with the metabolic syndrome.
    Ajjemami M; Ouatou S; Charoute H; Fakiri M; Rhaissi H; Benrahma H; Rouba H; Barakat A
    J Diabetes Metab Disord; 2015; 14():29. PubMed ID: 25909077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of associations between apolipoprotein A5 and C3 gene polymorphisms with plasma triglyceride and lipid levels.
    Taşkin E; Bağci H; Turan MK
    Rev Assoc Med Bras (1992); 2023; 69(3):415-420. PubMed ID: 36921196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association analysis of APOA5 rs662799 and rs3135506 polymorphisms with obesity in Moroccan patients.
    Lakbakbi El Yaagoubi F; Charoute H; Bakhchane A; Ajjemami M; Benrahma H; Errouagui A; Kandil M; Rouba H; Barakat A
    Pathol Biol (Paris); 2015 Dec; 63(6):243-7. PubMed ID: 26524954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOA5 variants and metabolic syndrome in Caucasians.
    Grallert H; Sedlmeier EM; Huth C; Kolz M; Heid IM; Meisinger C; Herder C; Strassburger K; Gehringer A; Haak M; Giani G; Kronenberg F; Wichmann HE; Adamski J; Paulweber B; Illig T; Rathmann W
    J Lipid Res; 2007 Dec; 48(12):2614-21. PubMed ID: 17768309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of APOA5 Gene Promoter Region -1131T>C Polymorphism (rs662799) to Plasma Triglyceride Level in Patients with Type 2 Diabetic Nephropathy.
    Mahrooz A; Zargari M; Ansari V; Makhlough A; Hashemi-Sooteh MB
    J Clin Diagn Res; 2016 May; 10(5):BC09-13. PubMed ID: 27437205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
    Niculescu LS; Vlădică M; Sima AV
    Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Association of Apolipoprotein A5-1131T>C Polymorphism with Traits of Metabolic Syndrome.
    Zafar U; Khaliq S; Lone KP
    J Coll Physicians Surg Pak; 2019 Jul; 29(7):626-630. PubMed ID: 31253212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of APOA5 -1131T>C and S19W gene polymorphisms with both mild hypertriglyceridemia and hyperchylomicronemia in type 2 diabetic patients.
    Charriere S; Bernard S; Aqallal M; Merlin M; Billon S; Perrot L; Le Coquil E; Sassolas A; Moulin P; Marcais C
    Clin Chim Acta; 2008 Aug; 394(1-2):99-103. PubMed ID: 18468520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants of apolipoprotein A5 T-1131C and apolipoprotein E common polymorphisms and their relationship to features of metabolic syndrome in adult dyslipidemic patients.
    Novotny D; Vaverkova H; Karasek D; Malina P
    Clin Biochem; 2014 Aug; 47(12):1015-21. PubMed ID: 24709297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of APOA5 rs662799 and rs3135506 polymorphisms with arterial hypertension in Moroccan patients.
    Ouatou S; Ajjemami M; Charoute H; Sefri H; Ghalim N; Rhaissi H; Benrahma H; Barakat A; Rouba H
    Lipids Health Dis; 2014 Apr; 13():60. PubMed ID: 24684850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
    Kim JY; Kim OY; Paik JK; Lee SH; Lee JH
    J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease.
    Jang Y; Paik JK; Hyun YJ; Chae JS; Kim JY; Choi JR; Lee SH; Shin DJ; Ordovas JM; Lee JH
    Clin Chim Acta; 2009 Apr; 402(1-2):83-7. PubMed ID: 19159622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study.
    Lai CQ; Demissie S; Cupples LA; Zhu Y; Adiconis X; Parnell LD; Corella D; Ordovas JM
    J Lipid Res; 2004 Nov; 45(11):2096-105. PubMed ID: 15342688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.